Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies
South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at...
SK bioscience partners with Novavax on Covid-19 vaccine
South Korea-based SK bioscience has entered into a development and supply agreement for Novavax Covid-19...
Samsung Biologics to build fourth manufacturing plant
South Korea-based biomedicine maker Samsung Biologics has unveiled plans to build its fourth plant this...
Daewoong finds niclosamide effective against Covid-19 in animal tests
South Korea-based Daewoong Pharmaceutical has found that its anti-parasitic drug niclosamide had removed SARS-CoV-2, the...
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19...
Vaxine and Medytox partner on Covid-19 vaccine development
Australian biotechnology company Vaxine has collaborated with South Korean biopharma company Medytox for the development...
Celltrion identifies antibody candidates against Covid-19
Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the...
Vir selects Samsung Biologics to produce Covid-19 antibodies
Immunology company Vir Biotechnology has selected South Korea-based Samsung Biologics for large-scale production of antibodies...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Coronavirus in South Korea: COVID-19 outbreak, measures and impact
Neighbouring two coronavirus-affected countries China and Japan, South Korea is among the top ten countries...